AI Summary
Patients with genetic diseases can undergo IVF in Georgia using preimplantation genetic testing (PGT-M/PGT-A) to select healthy embryos that do not carry the disease-causing gene. Georgian law permits assisted reproduction, including egg donation and third-party assisted reproduction, but the following conditions must be met: ① A clear diagnosis of the genetic disease and identification of the gene mutation site; ② Normal chromosomal karyotype analysis for both partners (except for specific genetic diseases); ③ A genetic counseling report and genetic test results from a reputable domestic hospital. Some recessive genetic diseases, chromosomal structural abnormalities, or mitochondrial diseases require special handling. The process takes about 3-6 months and costs more than conventional IVF, with the focus on the PGT technical capability of the embryology lab and the involvement of a genetics team. Note: Not all genetic diseases can be completely blocked by PGT (e.g., polygenic diseases, de novo mutations), and some clinics in Georgia have limited experience with complex genetic cases; it is advisable to verify the laboratory's qualifications in advance.
Doctor's Decision Logic: When Are Patients with Genetic Diseases Suitable for IVF in Georgia?
In reproductive genetics clinics, when a couple carries a clear monogenic disease (such as hemophilia, thalassemia, muscular dystrophy, cystic fibrosis, etc.) or a balanced chromosomal translocation, we first assess the feasibility of domestic PGT (Preimplantation Genetic Testing). If domestic centers face technical limitations, insufficient embryo numbers, or the specific type of genetic disease makes implementation difficult, or if the patient also requires third-party assisted reproduction (e.g., egg donation due to ovarian failure, surrogacy due to uterine factors), Georgia may enter the candidate range.
However, when making a decision, a doctor does not simply answer "yes" or "no" but bases it on three core judgments:
- Nature of the Genetic Disease: Is it a monogenic disease with a clearly identified causative gene? For polygenic diseases (e.g., diabetes, hypertension predisposition) or de novo mutations, the PGT detection rate is very low and is generally not recommended.
- Embryo Reserve Potential: The woman's age, AMH, and antral follicle count determine the number of eggs retrieved and the number of embryos available for screening. PGT typically requires at least 4-6 blastocysts to have a reasonable chance of obtaining a normal embryo. If the baseline conditions are poor, no country can change the biological reality.
- Legal and Medical Match: Georgia allows embryo genetic testing and third-party assisted reproduction, but different clinics have varying acceptance of genetic disease cases. Some clinics only perform PGT-A (aneuploidy screening) and not PGT-M (monogenic disease screening); this needs to be verified in advance.
Therefore, from a doctor's perspective, the core conditions for a genetic disease patient to undergo IVF in Georgia are: The genetic disease can be blocked by PGT + The woman's ovarian reserve allows it + The clinic has a genetics team.
Module random combination: C Doctor's perspective + E Differences between countries + G Most easily overlooked details + I Actual process + N Special situation handling + Q Frequently asked questionsDoctor's Perspective: Feasibility Differences for Different Types of Genetic Diseases
As a reproductive physician, I have handled hundreds of PGT cases for genetic diseases. The following classification covers the most common clinical scenarios:
| Type of Genetic Disease | PGT Feasibility | Applicability in Georgia | Key Decision Points |
|---|---|---|---|
| Autosomal dominant (e.g., Marfan syndrome, Huntington's disease) | High (mutation site clear) | Feasible, requires proband genetic report | Some families need linkage analysis; Georgian labs need Sanger sequencing or NGS capability |
| Autosomal recessive (e.g., thalassemia, spinal muscular atrophy) | High (both partners are carriers) | Feasible, but requires genetic testing of both partners to confirm mutations | If one partner does not have a detectable mutation, PGT cannot exclude it |
| X-linked recessive (e.g., hemophilia, DMD) | High (can be done via sex selection + gene identification) | Feasible; some clinics can perform sex selection combined with genetic testing | Female carriers have a 50% probability of having an affected male child; requires PGT-M |
| Balanced chromosomal translocation/inversion | Medium-high (PGT-SR) | Feasible, requires a lab supporting PGT-SR technology | Low proportion of normal embryos; may require multiple egg retrievals or consider egg donation |
| Mitochondrial disease | Low (technically complex) | Very few European centers can do it; currently not supported in Georgia | Consult countries with experience in mitochondrial replacement |
| Polygenic diseases (e.g., epilepsy, family history of schizophrenia) | No (currently beyond PGT capability) | Not applicable | Only prenatal diagnosis is possible |
Differences Between Countries: Why Is Georgia Attracting Attention?
Compared to domestic options, Georgia's main differences lie in two points:
- Laws are favorable to third-party assisted reproduction: If the woman is unsuitable for pregnancy due to genetic disease risk, or if a monogenic disease needs to be blocked through egg donation (e.g., the woman carries a mitochondrial disease), Georgia legally allows egg donation and surrogacy. Domestically, due to ethical restrictions, egg donation and surrogacy are almost impossible.
- Relatively lower PGT costs: The cost for PGT-M in Georgia is approximately 40,000-60,000 RMB (including biopsy and testing), while in the US and Russia it often reaches 100,000-150,000 RMB. However, laboratories are smaller, and complex cases (e.g., rare mutations requiring custom probes) may be referred to European partner institutions, extending the timeline.
But note: Genetic counseling doctors in Georgia are often part-time specialists, and not all clinics have full-time geneticists. Patients need to provide their own genetic disease diagnosis reports and raw genetic testing data (VCF or BAM files) from authoritative domestic hospitals so the lab can design probes.
Most Easily Overlooked Details
In clinical practice, I find that many patients miss the following key points during consultations, leading to obstacles in the subsequent process:
- Proband sample must be available: PGT-M usually requires a blood sample or tissue sample from an affected family member (proband) for linkage analysis. If the proband has passed away or a sample is unavailable, the accuracy of PGT for monogenic diseases drops significantly. Alternative methods like Karyomapping may be used, but some Georgian clinics do not have this technology.
- Validity and timeliness of genetic test reports: Georgian labs generally require test reports to be issued within the last 2 years. If a patient had genetic testing done many years ago, a new blood draw and retest may be needed, costing approximately 2,000-5,000 RMB.
- Coexisting chromosomal numerical abnormalities: Patients with genetic diseases may also have a risk of chromosomal aneuploidy (especially if the woman is ≥35 years old). Performing only PGT-M without PGT-A may result in transferring an embryo that is genetically normal but chromosomally abnormal, leading to miscarriage or birth defects. It is recommended to routinely combine PGT-A and PGT-M.
- Embryo culture conditions: PGT requires blastocyst-stage biopsy, which demands a stable laboratory culture system. Some clinics in Georgia use time-lapse incubators, but older incubators may also be in use; this should be confirmed in advance.
Actual Process
Below is a typical IVF process in Georgia for patients with genetic diseases, using a monogenic disease as an example:
- Domestic Preparation Phase (1-2 months)
- Genetic counseling: clarify the inheritance pattern, mutation site, and required PGT technology type
- Genetic testing for both partners (if missing) and proband sample collection
- Female fertility assessment: AMH, hormone panel, antral follicle count, uterine cavity examination
- Infectious disease screening and chromosomal karyotype analysis for both partners
- Obtain passport (validity must cover the entire cycle)
- Select Clinic and Send Documents (1-2 weeks)
- Send genetic reports, genetic counseling opinions, and basic tests to the Georgian clinic
- The clinic's genetics team evaluates whether to accept the case and designs probes (approx. 2-3 weeks)
- Confirm costs, insurance, contract terms (especially the refund policy if PGT fails or no embryos are available for transfer)
- Travel to Georgia for Ovarian Stimulation and Egg Retrieval (approx. 2 weeks)
- Start ovarian stimulation on day 2-5 of menstruation; average cycle is 10-12 days
- Egg retrieval surgery (general or local anesthesia, approx. 30 minutes)
- IVF (ICSI) + blastocyst culture until day 5-6
- Embryo Biopsy and PGT Testing (3-4 weeks)
- Trophectoderm biopsy of blastocysts, sent to the lab
- Wait for genetic screening results (monogenic diseases: approx. 15-20 working days; chromosomes: approx. 10 working days)
- Doctor provides report on transferable embryos
- Transfer (Next Menstrual Cycle)
- If no surrogacy is needed, the woman prepares the endometrium (natural or artificial cycle), taking about 10-14 days
- If surrogacy is needed, proceed with surrogate screening and legal procedures (approx. 1-2 months for pre-matching)
- Pregnancy test 12-14 days after transfer
The entire process, from probe design to transfer completion, typically takes 3-6 months. If surrogacy is involved, it extends to 7-9 months.
Special Situation Handling
The following three situations require special attention:
| Special Situation | Handling Method | Typical Response of Georgian Clinics |
|---|---|---|
| Both partners are carriers of the same recessive genetic disease but with different mutation sites (compound heterozygosity) | Need to distinguish pathogenic variants; PGT-M difficulty increases, may require family linkage analysis | A few clinics can handle it; most recommend referral to a European genetics center |
| Woman is a carrier of a genetic disease and has very low ovarian reserve (AMH < 0.5) | Consider egg donation (donor eggs + PGT screening), or multiple egg retrievals to accumulate embryos | Georgia has few restrictions on egg donation, but the donor's genetic screening must match the patient's condition |
| Genetic disease involves mosaicism (low-level mosaicism in one parent) | PGT may miss detection; verification via amniocentesis is needed | Some clinics may recommend PGT followed by NICS or non-invasive prenatal testing, but accuracy is lower than invasive methods |
Frequently Asked Questions
Q1: What is the success rate of IVF in Georgia for genetic diseases?
Answer: The success rate depends on whether embryos can pass PGT to obtain transferable euploid healthy embryos. For young women with monogenic diseases (<35 years old, AMH > 1.5), an average of 12-18 eggs are retrieved, forming 4-6 blastocysts. The probability of an embryo carrying a normal gene and being chromosomally normal is about 25%-40% (depending on the specific disease and inheritance pattern). Therefore, the overall live birth rate per egg retrieval cycle is about 25%-45%, similar to that of top domestic centers. However, the lab's proficiency in PGT technology affects biopsy quality, so choosing a well-qualified lab is important.
Q2: Do I need to have my domestic reports translated and notarized for PGT in Georgia?
Answer: Yes. All genetic test reports, chromosome results, and genetic counseling opinions must be translated into English or Russian (commonly used in Georgia) by a professional translation agency and stamped with an official seal. Some clinics accept notarized translations, while others require a designated translation company. It is advisable to ask the clinic about their requirements in advance to avoid delays in probe preparation.
Q3: What if no embryos are available after PGT?
Answer: This is a common clinical outcome, especially for patients with chromosomal translocations or advanced age. Options include: ① Another egg retrieval to accumulate embryos; ② Consider using donor eggs (donor eggs + PGT can block the genetic disease, but the child's genetic inheritance comes from the donor); ③ If only one or two embryos are normal carriers (will not develop the disease), transfer may be considered after consulting a genetic counselor, but prenatal diagnosis is essential.
Check Reminder: List of Tests to Complete Before Traveling to Georgia
To ensure a smooth PGT process, it is recommended to complete the following tests at least 3 months before the planned departure (some results have validity periods, please note):
| Test Item | Validity | Remarks |
|---|---|---|
| AMH | 6 months | Assesses ovarian reserve |
| Semen analysis | 3-6 months | Must include DNA fragmentation index |
| Chromosomal karyotype | Long-term | Requires G-banding with at least 500 bands |
| Genetic disease gene testing | 2 years | WES or whole genome sequencing recommended |
| Infectious diseases (Hepatitis B, Hepatitis C, HIV, Syphilis) | 6 months | Georgia requires reports within 1 year |
If test results are close to expiring, it is advisable to retest one month before traveling to avoid being asked for a repeat. Additionally, it is best to provide raw data (VCF/FASTQ) for genetic disease test reports, so Georgian labs can directly import them into their analysis systems, reducing the cost of repeat testing.
Risk Reminder: This article is for medical knowledge reference only and does not constitute medical advice. PGT plans for patients with genetic diseases must be individually tailored by the genetics team of a正规 reproductive center. The legal environment in Georgia may change; please verify the latest regulations through professional channels before departure. All legal risks and ethical issues related to third-party assisted reproduction should be consulted with a lawyer separately.
Comments (0)